GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » ROE % Adjusted to Book Value

Psyence Biomedical (Psyence Biomedical) ROE % Adjusted to Book Value : 0.00% (As of Mar. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical ROE % Adjusted to Book Value?

Psyence Biomedical's ROE % for the quarter that ended in Mar. 2023 was -418.80%. Psyence Biomedical's PB Ratio for the quarter that ended in Mar. 2023 was N/A. Psyence Biomedical's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2023 was N/A.


Psyence Biomedical ROE % Adjusted to Book Value Historical Data

The historical data trend for Psyence Biomedical's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical ROE % Adjusted to Book Value Chart

Psyence Biomedical Annual Data
Trend Mar21 Mar22 Mar23
ROE % Adjusted to Book Value
- - -

Psyence Biomedical Semi-Annual Data
Mar21 Mar22 Mar23
ROE % Adjusted to Book Value - - -

Competitive Comparison of Psyence Biomedical's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Psyence Biomedical's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Psyence Biomedical's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Psyence Biomedical's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Psyence Biomedical's ROE % Adjusted to Book Value falls into.



Psyence Biomedical ROE % Adjusted to Book Value Calculation

Psyence Biomedical's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-418.80% / N/A
=N/A

Psyence Biomedical's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-418.80% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Psyence Biomedical ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Psyence Biomedical's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Psyence Biomedical (Psyence Biomedical) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines